Chemical Rubber Company critical reviews in oncology/hematology

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

NL

tipo

journal

publicação venue de

Clinical and molecular overview of immunotherapeutic approaches for malignant skin melanoma: Past, present and future. 186:103988. 2023-01-01
Correlation of Bcl-2 Expression with Prognosis and Survival in Patients with Head and Neck Cancer: A Systematic Review and Meta-Analysis. 23:104021. 2023-01-01
Drug-based therapy for advanced adenoid cystic carcinoma: Current landscape and challenges based on an overview of registered clinical trials. 181:103886. 2023-01-01
Effects and moderators of exercise medicine on cardiometabolic outcomes in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis. 186:103995. 2023-01-01
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review. 104116:104116. 2023-01-01
Systemic therapy for advanced cervical cancer: Leveraging the historical threshold of overall survival. 183:103925. 2023-01-01
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years? experience of association studies to understand the genetic architecture of pancreatic cancer. 186:104020. 2023-01-01
Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: different clinical outcomes to the same tumor. 179:103792. 2022-01-01
Can inflammasomes promote the pathophysiology of glioblastoma multiforme? A view about the potential of the anti-inflammasome therapy as pharmacological target. 1:103641-1. 2022-01-01
Cellular reprogramming, chemoresistance, and dietary interventions in breast cancer. 1:103796. 2022-01-01
Corrigendum to -SELNET clinical practice guidelines for bone sarcoma- Critical reviews in oncology/hematology, vol. 174 (2022), 1-10. 180:103827. 2022-01-01
Gene expression signatures in early Breast Cancer: better together with clinicopathological features.. 1:103708. 2022-01-01
Hadrontherapy techniques for breast cancer. 169:103574. 2022-01-01
Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy. 180:103863. 2022-01-01
MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions. 176:103745. 2022-01-01
P16 gene promoter methylation is associated with oncogenesis and progression of gastric carcinomas: A systematic review and meta-analysis. 180:103843. 2022-01-01
Patient reported outcomes in the daily practice in clinical oncology: A systematic review. 173:103658. 2022-01-01
SELNET clinical practice guidelines for bone sarcoma. 174:103685. 2022-01-01
Salivary gland cancer in the setting of tumor microenvironment: Translational routes for therapy. -:103605-1. 2022-01-01
Single nucleotide polymorphisms to predict acute radiation dermatitis in breast cancer patients: A systematic review and meta-analysis. 15 Mar:103651. 2022-01-01
The Current Staging and Classification Systems of Breast Cancer and Their Pitfalls: Is It Possible to Integrate the Complexity of this Neoplasm into a Unified Staging System?. 178:103781. 2022-01-01
CD200 expression in hematopoietic neoplasms: beyond a marker for diagnosis of B-cell neoplasms. -:103509. 2021-01-01
Cell signaling pathways as molecular targets to eliminate AML stem cells. 160:103277. 2021-01-01
Chemotherapy in focus: a meta-analysis confronts immunotherapy in the treatment of advanced melanoma. 161:103304. 2021-01-01
DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs. 164:103399. 2021-01-01
Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion. 157:103200. 2021-01-01
Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas. 167:103496. 2021-01-01
Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis. 1:103349-284. 2021-01-01
Epigenetic modulation of the tumor microenvironment in head and neck cancer: Challenges and opportunities. 164:103397. 2021-01-01
Exposure to endocrine disruptors and risk of breast cancer: A systematic review. 00:103330. 2021-01-01
Extranodal NK/T cell lymphoma, nasal type: An updated overview. 159:103237. 2021-01-01
Hematopoietic stem cell stretches and moves in its bone marrow niche. 1:103368-1. 2021-01-01
Impact of immune cells on the hallmarks of cancer: a literature review. 168:103541. 2021-01-01
Impact of tumor site on the prognosis of salivary gland neoplasms: a systematic review and meta-analysis. 162:103352. 2021-01-01
Late radiation effects in survivors of head and neck cancer: State of the science. 162:103335. 2021-01-01
Long non-coding RNAs regulate the hallmarks of cancer in HPV-induced malignancies. xx:103310-xxx. 2021-01-01
Molecular landscape of Hereditary Melanoma. 164:103425. 2021-01-01
Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy. 162:103340. 2021-01-01
Sequential therapies for advanced urothelial cancer: Hope meets new challenges. 160:103248. 2021-01-01
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. 163:103391. 2021-01-01
Two sides of the same coin: Insights into the myoepithelial cells in carcinoma ex pleomorphic adenoma development. 157:103195. 2021-01-01
Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting. 160:103281. 2021-01-01
Worldwide Prevalence of PI3K-AKT-mTOR Pathway Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis. 160:103284. 2021-01-01
Adjuvant treatment of endometrial cancer in molecular era: are we ready to move on?. 153:103016. 2020-01-01
Does laser photobiomodulation prevent hyposalivation in patients undergoing head and neck radiotherapy? A systematic review and meta-analysis of controlled trials. 156:103115. 2020-01-01
Global frequency and distribution of head and neck cancer in pediatrics, a systematic review. 148:102892. 2020-01-01
Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. 156:103116-116. 2020-01-01
Head and neck cancer patient-derived xenograft models - A systematic review. 1:103087-103087. 2020-01-01
Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis. 150:102966. 2020-01-01
Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects. 156:103111. 2020-01-01
Metabolic rewiring in melanoma drug-resistant cells. 153:102995. 2020-01-01
Oral potentially malignant disorders: A scoping review of prognostic biomarkers. 153:102986. 2020-01-01
Patients with lung cancer undergoing immune checkpoint inhibitors: a meta-analysis of dermatological toxicities. 1:102983-0. 2020-01-01
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group. 153:103033. 2020-01-01
The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review. 156:103090. 2020-01-01
Triple negative breast cancer: A thorough review of biomarkers. 145:102855. 2020-01-01
ctDNA as a cancer biomarker: a broad overview. 155:103109. 2020-01-01

tem uma área de assunto

publisher

Elsevier BV

is open access

False invalid format

is in DOAJ

False invalid format